Lu M - Search Results

1

Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus.

Zhang Y, Zhang Y, Kang Y, Wang J, Liu H, Zhu H, Qin Y, Mao R, Lin X, Lu M, Zhang J. Zhang Y, et al. Among authors: lu m. J Virol Methods. 2014 Jun;201:51-6. doi: 10.1016/j.jviromet.2014.02.008. Epub 2014 Feb 28. J Virol Methods. 2014. PMID: 24583110

2

Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy.

Zhang JM, Wang XY, Huang YX, Yin YK, Guan S, Xu Y, Roggendorf M, Lu M. Zhang JM, et al. Among authors: lu m. J Med Virol. 2006 Mar;78(3):324-8. doi: 10.1002/jmv.20543. J Med Virol. 2006. PMID: 16419112

3

Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.

Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M. Zhang JM, et al. Among authors: lu m. Clin Infect Dis. 2007 May 1;44(9):1161-9. doi: 10.1086/513200. Epub 2007 Mar 19. Clin Infect Dis. 2007. PMID: 17407033

4

Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA.

Meng Z, Xu Y, Wu J, Tian Y, Kemper T, Bleekmann B, Roggendorf M, Yang D, Lu M. Meng Z, et al. Among authors: lu m. J Virol Methods. 2008 Jun;150(1-2):27-33. doi: 10.1016/j.jviromet.2008.02.008. Epub 2008 Apr 18. J Virol Methods. 2008. PMID: 18378325 Free PMC article.

5

Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expression.

Meng Z, Qiu S, Zhang X, Wu J, Schreiter T, Xu Y, Yang D, Roggendorf M, Schlaak J, Lu M. Meng Z, et al. Among authors: lu m. Virology. 2009 Feb 5;384(1):88-96. doi: 10.1016/j.virol.2008.11.012. Epub 2008 Dec 6. Virology. 2009. PMID: 19064272 Free article.

6

Spontaneous HBeAg seroconversion and loss of hepatitis B virus DNA after acute flare due to development of drug resistant mutants during entecavir monotherapy.

Mao RC, Yin YK, Qin YL, Wu XH, Weng XH, Zhang JM, Lu M. Mao RC, et al. Among authors: lu m. Hepatol Res. 2009 Jan;39(1):14-20. doi: 10.1111/j.1872-034X.2008.00411.x. Hepatol Res. 2009. PMID: 19125938

7

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1.

Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, Lu M. Zhang X, et al. Among authors: lu m. Hepatology. 2011 May;53(5):1476-85. doi: 10.1002/hep.24195. Hepatology. 2011. PMID: 21520166

8

DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.

Yin Y, Wu C, Song J, Wang J, Zhang E, Liu H, Yang D, Chen X, Lu M, Xu Y. Yin Y, et al. Among authors: lu m. PLoS One. 2011;6(7):e22524. doi: 10.1371/journal.pone.0022524. Epub 2011 Jul 22. PLoS One. 2011. PMID: 21799884 Free PMC article.

9

Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.

Zhang X, Ma Z, Liu H, Liu J, Meng Z, Broering R, Yang D, Schlaak JF, Roggendorf M, Lu M. Zhang X, et al. Among authors: lu m. J Hepatol. 2012 Sep;57(3):522-8. doi: 10.1016/j.jhep.2012.05.004. Epub 2012 May 19. J Hepatol. 2012. PMID: 22617154

10

The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir.

Qin B, Budeus B, Cao L, Wu C, Wang Y, Zhang X, Rayner S, Hoffmann D, Lu M, Chen X. Qin B, et al. Among authors: lu m. Antiviral Res. 2013 Feb;97(2):93-100. doi: 10.1016/j.antiviral.2012.12.007. Epub 2012 Dec 20. Antiviral Res. 2013. PMID: 23261845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,479 results

Search Page

Filters